S100B protein in neurodegenerative disorders

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Clinical Chemistry and Laboratory Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1515/CCLM.2011.083PMID 21303299
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glial pathology is modified by age in mood disorders--a systematic meta-analysis of serum S100B in vivo studies.

  2011cited by this paper
• S100B Protein, A Damage-Associated Molecular Pattern Protein in the Brain and Heart, and Beyond

  2010influential reference
• Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain.

  2010influential reference
• S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin Resistance

  2010cited by this paper
• CSF glial markers correlate with survival in amyotrophic lateral sclerosis

  2010influential reference
• Adipocytes as an Important Source of Serum S100B and Possible Roles of This Protein in Adipose Tissue

  2010cited by this paper
• Elevated S100B levels in schizophrenia are associated with insulin resistance

  2010cited by this paper
• Haloperidol and clozapine decrease S100B release from glial cells.

  2010cited by this paper
• Neuropathology of non-Alzheimer degenerative disorders.

  2010cited by this paper
• S100B serum levels are closely correlated with body mass index: an important caveat in neuropsychiatric research.

  2010cited by this paper
• Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients

  2010cited by this paper
• Mood Disorders Are Glial Disorders: Evidence from In Vivo Studies

  2010influential reference
• Serum levels of S100B and NSE proteins in Alzheimer's disease patients

  2010influential reference
• S100B's double life: intracellular regulator and extracellular signal.

  2009cited by this paper
• Glial Fibrillary Acidic Protein and Protein S-100B: Different Concentration Pattern of Glial Proteins in Cerebrospinal Fluid of Patients with Alzheimer's Disease and Creutzfeldt-Jakob Disease

  2009influential reference
• Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy

  2009cited by this paper
• Association Study of Astrocyte-Derived Protein S100B Gene Polymorphisms with Major Depressive Disorder in Chinese People

  2009cited by this paper
• A new pathophysiological aspect of S100B in schizophrenia: potential regulation of S100B by its scavenger soluble RAGE.

  2009cited by this paper
• Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders

  2009cited by this paper
• S100A7, a Novel Alzheimer's Disease Biomarker with Non-Amyloidogenic α-Secretase Activity Acts via Selective Promotion of ADAM-10

  2009cited by this paper
• Guidelines for the next 10 years of proteomics

  2009cited by this paper
• Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease

  2009cited by this paper
• Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia--original research and meta-analysis.

  2009cited by this paper
• Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood.

  2008cited by this paper
• S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study.

  2008cited by this paper
• No Association of the rs9722 C >T in the S100B Gene and Susceptibility to Major Depression in a Chinese Population

  2008cited by this paper
• Serum markers support disease-specific glial pathology in major depression.

  2008cited by this paper
• S100 protein family and its application in clinical practice.

  2008cited by this paper
• Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases

  2008cited by this paper
• A simple, sensitive and widely applicable ELISA for S100B: Methodological features of the measurement of this glial protein.

  2008cited by this paper
• Receptor for Advanced Glycation End Products Is Subjected to Protein Ectodomain Shedding by Metalloproteinases*

  2008influential reference
• S100B is expressed in, and released from, OLN-93 oligodendrocytes: Influence of serum and glucose deprivation.

  2008cited by this paper
• Effect of the atypical neuroleptic risperidone on morphology and S100B secretion in C6 astroglial lineage cells

  2008cited by this paper
• Evidence for a wide extra-astrocytic distribution of S100B in human brain

  2007influential reference
• RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins.

  2007cited by this paper
• Candidate gene analysis of 21q22: Support for S100B as a susceptibility gene for bipolar affective disorder with psychosis

  2007cited by this paper
• S100B protein is released from rat neonatal neurons, astrocytes, and microglia by in vitro trauma and anti‐S100 increases trauma‐induced delayed neuronal injury and negates the protective effect of exogenous S100B on neurons

  2007cited by this paper
• Gliogenesis and glial pathology in depression.

  2007cited by this paper
• Glial cell activation in a subgroup of patients with schizophrenia indicated by increased S100B serum concentrations and elevated myo-inositol.

  2007cited by this paper
• The role of oligodendrocyte pathology in schizophrenia.

  2007cited by this paper
• S100B binding to RAGE in microglia stimulates COX‐2 expression

  2007cited by this paper
• S100B in neuropathologic states: The CRP of the brain?

  2007cited by this paper
• Evidence for the association of the S100β gene with low cognitive performance and dementia in the elderly

  2007cited by this paper
• Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target.

  2006cited by this paper
• Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease.

  2006cited by this paper
• Serum S100B protein is increased in fasting rats.

  2006cited by this paper
• An update of the S100 nomenclature.

  2006cited by this paper
• Glutamate Uptake Is Stimulated by Extracellular S100B in Hippocampal Astrocytes

  2006cited by this paper
• Brain abnormalities in human obesity: A voxel-based morphometric study

  2006cited by this paper
• S100B protects LAN‐5 neuroblastoma cells against Aβ amyloid‐induced neurotoxicity via RAGE engagement at low doses but increases Aβ amyloid neurotoxicity at high doses

  2006cited by this paper
• Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones

  2006cited by this paper
• Active secretion of S100B from astrocytes during metabolic stress.

  2006cited by this paper
• Regionally Specific Changes in Levels of Cortical S100β in Bipolar 1 Disorder but not Schizophrenia

  2006cited by this paper
• REporting recommendations for tumor MARKer prognostic studies (REMARK)

  2005cited by this paper
• Enhanced Hippocampal Neurogenesis by Intraventricular S100B Infusion Is Associated with Improved Cognitive Recovery after Traumatic Brain Injury

  2005cited by this paper
• S100b counteracts effects of the neurotoxicant trimethyltin on astrocytes and microglia

  2005cited by this paper
• Oligodendrocytes damage in Alzheimer's disease: beta amyloid toxicity and inflammation.

  2005cited by this paper
• Tau Protein, Aβ42 and S-100B Protein in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies

  2005cited by this paper
• Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.

  2005cited by this paper
• Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies.

  2005cited by this paper
• SNPs and haplotypes in the S100B gene reveal association with schizophrenia.

  2005cited by this paper
• Local regulation of the axonal phenotype, a case of merotrophism.

  2005cited by this paper
• REporting recommendations for tumour MARKer prognostic studies (REMARK)

  2005cited by this paper
• S100B and NSE serum concentrations in Machado Joseph disease.

  2005cited by this paper
• Comparison of four different assays for determination of serum S-100B.

  2005cited by this paper
• REporting recommendations for tumour MARKer prognostic studies (REMARK)

  2005cited by this paper
• S100B and NSE serum levels in patients with Parkinson's disease.

  2005influential reference
• S100B protein in clinical diagnostics: assay specificity.

  2004cited by this paper
• Intraventricular Infusion of the Neurotrophic Protein S100B Improves Cognitive Recovery after Fluid Percussion Injury in the Rat

  2004cited by this paper
• Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease.

  2004cited by this paper
• S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma.

  2004cited by this paper
• Nuclear expression of S100B in oligodendrocyte progenitor cells correlates with differentiation toward the oligodendroglial lineage and modulates oligodendrocytes maturation.

  2004cited by this paper
• Relationship between stress and circulating levels of S100B protein.

  2004cited by this paper
• Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF

  2004cited by this paper
• A distinctive distribution of reactive astroglia in the precentral cortex in amyotrophic lateral sclerosis

  2004influential reference
• Course and Long-Term Treatment of Schizophrenic Psychoses

  2004cited by this paper
• The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration

  2003cited by this paper
• Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum

  2003influential reference
• S100B in brain damage and neurodegeneration

  2003cited by this paper
• Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease.

  2003influential reference
• The Janus face of glial-derived S100B: Beneficial and detrimental functions in the brain

  2003influential reference
• Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia.

  2003cited by this paper
• Proteins in cerebrospinal fluid and blood: Barriers, CSF flow rate and source-related dynamics

  2003cited by this paper
• Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.

  2003cited by this paper
• Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia.

  2002cited by this paper
• Glial protein S100B modulates long-term neuronal synaptic plasticity

  2002cited by this paper
• Oligodendrocytes as providers of growth factors

  2002cited by this paper
• S100B proteins that lack one or both cysteine residues can induce inflammatory responses in astrocytes and microglia.

  2001cited by this paper
• Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease.

  2001influential reference
• Dynamics of brain-derived proteins in cerebrospinal fluid.

  2001cited by this paper
• Fluoxetine increases the content of neurotrophic protein S100beta in the rat hippocampus.

  2001cited by this paper
• Neurotrophic factor S100 beta in major depression.

  2001cited by this paper
• S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles.

  2001cited by this paper
• Astrocytes degenerate in frontotemporal dementia: possible relation to hypoperfusion.

  2001influential reference
• Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology

  2001cited by this paper
• Neurotrophic Factor S100beta in Major Depression

  2001cited by this paper
• Elimination of S100B and renal function after cardiac surgery.

  2000cited by this paper
• Immunocontent and secretion of S100B in astrocyte cultures from different brain regions in relation to morphology

  2000cited by this paper
• Overexpression of S100β in Down’s syndrome: correlation with patient age and with β‐amyloid deposition

  1999cited by this paper
• S-100β protein is upregulated in astrocytes and motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis

  1999cited by this paper

• The role of autoantibodies in Alzheimer's disease: Pathogenetic connections or epiphenomena?

  2025cites this paper
• Relationship of S100 Proteins with Neuroinflammation

  2025cites this paper
• Machine learning helps predict early onset psychosis with serum protein biomarkers, neuropsychometry, and clinicodemographic data

  2025cites this paper
• Synaptic dysfunction and glial activation markers throughout aging and early neurodegeneration: a longitudinal CSF biomarker-based study

  2025cites this paper
• Plasma S100β is a predictor for pathology and cognitive decline in Alzheimer’s disease

  2025cites this paper
• The aging interactome: From cellular dysregulation to therapeutic frontiers in age-related diseases.

  2025cites this paper
• Diverse role of S100 calcium-binding protein B in alzheimer’s disease: pathological mechanisms and therapeutic implications

  2025cites this paper
• Predictors of delayed encephalopathy after acute carbon monoxide poisoning: a literature review

  2025cites this paper
• Higher blood-brain barrier leakage in schizophrenia-spectrum disorders: A comparative dynamic contrast-enhanced magnetic resonance imaging study with healthy controls.

  2025cites this paper
• Mechanistic Role of Astrocytic Rac1 Protein in Alzheimer's Disease.

  2025cites this paper
• Cerebrospinal Fluid Biomarkers of NLRP3 Pathway, Immune Dysregulation, and Neurodegeneration in Parkinson's Disease: A Meta‐Analysis

  2025cites this paper
• Preliminary Analysis of Potentially Overlapping Differentially Expressed Proteins in Both the Spinal Cord and Brain of SOD1 G93A Mice.

  2024cites this paper
• Astrocyte DNA damage and response upon acute exposure to ethanol and corticosterone

  2024cites this paper
• Multimodal Approach to Neurocognitive Function in People Living with HIV in the cART Era: A Comprehensive Review

  2024cites this paper
• Serum S100β Levels Are Linked with Cognitive Decline and Peripheral Inflammation in Spinocerebellar Ataxia Type 2

  2024cites this paper
• Gastrodin inhibits reactive astrocyte-mediated inflammation in hypoxic-ischemic brain damage through S100B/RAGE-Smad3 signaling

  2024cites this paper
• Surface-Enhanced Raman Scattering Nanoendoscope for Quantification of a Protein Released under Physiological Stimulation in Brain Tissue.

  2024cites this paper
• The immunomodulatory effects of psychedelics in Alzheimer's disease-related dementia.

  2024cites this paper
• Intracellular DAMPs in Neurodegeneration and Their Role in Clinical Therapeutics

  2023cites this paper
• Multiplexed Quantitative Proteomics Reveals Proteomic Alterations in Two Rodent Traumatic Brain Injury Models.

  2023cites this paper
• Profiling the autoantibody repertoire reveals autoantibodies associated with mild cognitive impairment and dementia

  2023cites this paper
• Biomarkers of Spinal Cord Injury in Patients Undergoing Complex Endovascular Aortic Repair Procedures—A Narrative Review of Current Literature

  2023cites this paper
• Prediction of Normal Tissue Complication Probability (NTCP) After Radiation Therapy Using Imaging and Molecular Biomarkers and Multivariate Modelling

  2023influential citation
• Mini review: Current status and perspective of S100B protein as a biomarker in daily clinical practice for diagnosis and prognosticating of clinical outcome in patients with neurological diseases with focus on acute brain injury

  2023influential citation
• Characterization of Macroglia Response during Tissue Repair in a Laser-Induced Model of Retinal Degeneration

  2023cites this paper
• Biomarkers: Role and Scope in Neurological Disorders

  2023cites this paper
• Early Diagnosis of Alzheimer’s Disease: Moving Toward a Blood-Based Biomarkers Era

  2023influential citation
• Beyond the amyloid hypothesis: how current research implicates autoimmunity in Alzheimer’s disease pathogenesis

  2023cites this paper
• Effects of recreational SCUBA diving practiced once a week on neurohormonal response and myokines-mediated communication between muscles and the brain

  2023cites this paper
• RAGE Inhibitors for Targeted Therapy of Cancer: A Comprehensive Review

  2022cites this paper
• The Role of the S100 Protein Family in Glioma

  2022cites this paper
• Blood Biomarkers for the Diagnosis of Neurodegenerative Dementia: A Systematic Review

  2022cites this paper
• Increased Serum NSE and S100B Indicate Neuronal and Glial Alterations in Subjects Under 71 Years With Mild Neurocognitive Disorder/Mild Cognitive Impairment

  2022cites this paper
• Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease

  2022cites this paper
• Pharmacological and pathological relevance of S100 proteins in neurological disorders.

  2022cites this paper
• Hippocampus and its involvement in Alzheimer’s disease: a review

  2022cites this paper
• Role of S100β Glial Protein as a Serological Marker for Analysis of Acute Ischemic Stroke

  2021cites this paper
• Potential Fluid Biomarkers and a Prediction Model for Better Recognition Between Multiple System Atrophy-Cerebellar Type and Spinocerebellar Ataxia

  2021cites this paper
• Gross Pathology in Schizophrenia

  2021cites this paper
• Clinical significance of S100B protein in pregnant woman with early- onset severe preeclampsia.

  2021cites this paper
• Association between HSPA1B, S100B, and TNF genes polymorphisms and risks of chronic mercury poisoning

  2021cites this paper
• Systematic Assessment of 10 Biomarker Candidates Focusing on α‐Synuclein‐Related Disorders

  2021cites this paper
• MEDICAL AND BIOLOGICAL ASPECTS RELATED TO ASSESSMENT OF IMPACTS EXERTED BY RISK FACTORS ASSOCIATION BETWEEN HSPA1B , S100B , AND TNF- α GENE POLYMORPHISMS AND RISKS OF CHRONIC MERCURY POISONING

  2021cites this paper
• Glial and neuronal markers in bipolar disorder: A meta-analysis testing S100B and NSE peripheral blood levels.

  2020cites this paper
• Neuroprotective effect of poly(lactic-co-glycolic acid) nanoparticle-bound brain-derived neurotrophic factor in a permanent middle cerebral artery occlusion model of ischemia in rats.

  2020cites this paper
• The Interplay between Diabetes and Alzheimer’s Disease—In the Hunt for Biomarkers

  2020influential citation
• Alzheimer’s Disease: New Concepts on the Role of Autoimmunity and NLRP3 Inflammasome in the Pathogenesis of the Disease

  2020cites this paper
• Understanding Calcium-Dependent Conformational Changes in S100A1 Protein: A Combination of Molecular Dynamics and Gene Expression Study in Skeletal Muscle

  2020cites this paper
• Cerebrospinal fluid myelin basic protein is elevated in multiple system atrophy.

  2020cites this paper
• Lipopolysaccharide-Elicited Systemic Inflammation Induces Selective Vulnerability of Cerebral Cortex and Striatum of Developing Glutaryl-CoA Dehydrogenase Deficient (Gcdh−/−) Mice to Oxidative Stress

  2020influential citation
• Biochemical Parameters in Cognitive Functions

  2020cites this paper
• Biomarkers: Our Path Towards a Cure for Alzheimer Disease

  2020cites this paper
• NDT_A_267673 2479..2489

  2020cites this paper
• The potential roles of aquaporin 4 in amyotrophic lateral sclerosis

  2019cites this paper
• Comparison of neuroprotective effect of isoflurane and sevoflurane on cerebral ischemia

  2019cites this paper
• [Biomarkers of intrauterine growth restriction].

  2019cites this paper
• Dexmedetomidine reduces brain neuronal injuries but not clinical neurocognitive function in the elderly , compared to midazolam

  2019cites this paper
• Effects of Antipsychotic Treatment on S100B and Oxidative Stress in Patients with Schizophrenia

  2019cites this paper
• S100 Proteins in Alzheimer’s Disease

  2019cites this paper
• Sevoflurane reduces ischemic brain injury in rats with diet and streptozotocin-induced diabetes

  2018cites this paper
• [Neurospecific proteins in cerebrospinal fluid and in the bloodserum of patients with amyotrophic lateral sclerosis].

  2018cites this paper
• Patients with chronic insomnia disorder have increased serum levels of neurofilaments, neuron-specific enolase and S100B: does organic brain damage exist?

  2018cites this paper
• Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson’s disease diagnosis

  2018cites this paper
• Arterial stiffness induced by carotid calcification leads to cerebral gliosis mediated by oxidative stress

  2018cites this paper
• Neurodegenerative Markers are Increased in Postmortem BA21 Tissue from African Americans with Alzheimer’s Disease

  2017cites this paper
• Arundic Acid Prevents Developmental Upregulation of S100B Expression and Inhibits Enteric Glial Development

  2017influential citation
• Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net

  2017cites this paper
• Melatonin Promotes Brain-Derived Neurotrophic Factor (BDNF) Expression and Anti-Apoptotic Effects in Neonatal Hemolytic Hyperbilirubinemia via a Phospholipase (PLC)-Mediated Mechanism

  2017cites this paper
• Novel Presentation of Rosai-Dorfman Histiocytosis With a Prolonged Course of Cranial and Peripheral Neuropathies.

  2017cites this paper
• Effets des protéines S100A8 et S100A9 dans la différenciation cellulaire dans la leucémie myéloïde aiguë

  2017cites this paper
• SAPIENZA UNIVERSITY OF ROME Department of Physiology and Pharmacology

  2017cites this paper
• S100B Mediates Stemness of Ovarian Cancer Stem‐Like Cells Through Inhibiting p53

  2017cites this paper
• Specific age-related molecular alterations in the cerebellum of Down syndrome mouse models.

  2016cites this paper
• S100B suppresses the differentiation of C3H/10T1/2 murine embryonic mesenchymal cells into osteoblasts.

  2016cites this paper
• The role of S100B protein as a potential marker in affective disorders.

  2016cites this paper
• Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda

  2016cites this paper
• Chronic exposure of adult, postnatal and in utero rat models to low-dose 137Cesium: impact on circulating biomarkers

  2016cites this paper
• Brain injury biomarkers in the setting of cardiac surgery: Still a world to explore

  2016cites this paper
• Time‐dependent uptake and trafficking of vesicles capturing extracellular S100B in cultured rat astrocytes

  2016influential citation
• Autoantibodies in Alzheimer’s disease: potential biomarkers, pathogenic roles, and therapeutic implications

  2016cites this paper
• Methylglyoxal and carboxyethyllysine reduce glutamate uptake and S100B secretion in the hippocampus independently of RAGE activation

  2016cites this paper
• Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay

  2015cites this paper
• New developments and future opportunities in biomarkers for amyotrophic lateral sclerosis

  2015cites this paper
• Pax6 influences expression patterns of genes involved in neuro- degeneration

  2015cites this paper
• Diminished serum repetin levels in patients with schizophrenia and bipolar disorder

  2015cites this paper
• Self‐reported sleep disturbance is associated with Alzheimer's disease risk in men

  2015cites this paper
• Serum S100B level may be correlated with carbon monoxide poisoning.

  2015cites this paper
• Changes in Astroglial Markers in a Maternal Immune Activation Model of Schizophrenia in Wistar Rats are Dependent on Sex

  2015cites this paper
• Elevated Serum Levels of NSE and S-100β Correlate with Increased Risk of Acute Cerebral Infarction in Asian Populations

  2015cites this paper
• Study on the cognitive changes in STZ induceed diabetes with special reference to glial changes and immune activation in rat hippo campus

  2015cites this paper
• The role and potential mechanism of resveratrol in the prevention and control of epilepsy.

  2015cites this paper
• Resveratrol is neuroprotective and improves cognition in pentylenetetrazole-kindling model of epilepsy in rats Meng X J, Wang F

  2015cites this paper
• Rage (Receptor for Advanced Glycation End Products) in Melanoma Progression

  2014cites this paper
• Potential neurochemical links between cholesterol and suicidal behavior.

  2014cites this paper
• Elevated plasma S100B levels in high altitude hypobaric hypoxia do not correlate with acute mountain sickness

  2014cites this paper
• MicroRNAs with Specific Roles in Diabetes and Psychiatric Diseases

  2014cites this paper
• Normal Cerebellar Development in S100B-Deficient Mice

  2014cites this paper
• Resveratrol is Neuroprotective and Improves Cognition in Pentylenetetrazole-kindling Model of Epilepsy in Rats

  2014cites this paper
• Biochemical markers of neurodegeneration in hereditary diffuse leucoencephalopathy with spheroids

  2014cites this paper
• Pro-inflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine.

  2014cites this paper